| Literature DB >> 32364369 |
Cristina Fernández-Paz1, Sara Rojas2, Pablo Salcedo-Abraira2, Teresa Simón-Yarza3, Carmen Remuñán-López1, Patricia Horcajada2.
Abstract
Although nanoscaled metal-organic frameworks (nanoMOFs) are promising drug carriers, their appropriate formulation remains almost unexplored and basically restricted to intravenous routes. Lungs, beneficiating from a large absorption surface and low enzymatic presence, are a very attractive target for both local and systemic delivery. However, pulmonary nanoMOF formulation is a pending and defying task. Thus, we propose a pioneer nanoMOF-based microsphere system as a potential platform for pulmonary administration. A biocompatible nanoMOF was successfully encapsulated in mannitol by a simple and continuous spray-drying technique. Upon intratracheal administration to rats, the resulting formulation, exhibiting optimal properties (i.e., homogeneity, size, density, and spray-drying process yield), was able to release the intact nanoMOF carrier uniformly along the lungs, reaching the bronchioles and alveoli.Entities:
Keywords: MIL-100 nanoparticles; MOFs; mannitol; microencapsulation; pulmonary delivery
Year: 2020 PMID: 32364369 DOI: 10.1021/acsami.0c07356
Source DB: PubMed Journal: ACS Appl Mater Interfaces ISSN: 1944-8244 Impact factor: 9.229